Absci and AstraZeneca forge AI partnership to discover cancer treatments

Absci, a frontrunner in generative AI antibody discovery, has partnered with biopharmaceutical giant AstraZeneca to leverage AI in the quest for a novel cancer treatment. This collaboration will capitalise on Absci’s Integrated Drug Creation platform—seamlessly integrating with AstraZeneca’s expertise in oncology, aiming to expedite the discovery of a potentially game-changing cancer therapy. Under the agreement,... Read more »

The post Absci and AstraZeneca forge AI partnership to discover cancer treatments appeared first on AI News.

absci ai applications artificial intelligence astrazeneca biopharmaceutical cancer cancer treatment collaboration discovery expertise game generative health healthcare industries novel oncology partnership platform quest treatment will